Steven Bots

1.0k total citations
21 papers, 577 citations indexed

About

Steven Bots is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Steven Bots has authored 21 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 14 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Steven Bots's work include Inflammatory Bowel Disease (18 papers), Microscopic Colitis (13 papers) and Biosimilars and Bioanalytical Methods (4 papers). Steven Bots is often cited by papers focused on Inflammatory Bowel Disease (18 papers), Microscopic Colitis (13 papers) and Biosimilars and Bioanalytical Methods (4 papers). Steven Bots collaborates with scholars based in Netherlands, Norway and Canada. Steven Bots's co-authors include Geert D’Haens, K Gecse, Mark Löwenberg, Kim Nylund, F de Voogd, Odd Helge Gilja, Murray L. Barclay, Anne S. Strik, Cyriel Y. Ponsioen and Marjolijn Duijvestein and has published in prestigious journals such as Gastroenterology, Oncogene and Cochrane Database of Systematic Reviews.

In The Last Decade

Steven Bots

19 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Bots Netherlands 12 400 305 164 124 98 21 577
Lotte C. Dinesen United Kingdom 7 293 0.7× 255 0.8× 295 1.8× 35 0.3× 136 1.4× 11 623
Rintaro Moroi Japan 13 211 0.5× 119 0.4× 193 1.2× 83 0.7× 83 0.8× 65 504
G. Van Assche Belgium 6 506 1.3× 340 1.1× 337 2.1× 99 0.8× 41 0.4× 6 657
Dilip Parekh United States 12 138 0.3× 86 0.3× 388 2.4× 59 0.5× 484 4.9× 22 804
J. Frederik M. Slors Netherlands 17 283 0.7× 146 0.5× 772 4.7× 174 1.4× 576 5.9× 20 1.2k
Adriaan A. van Bodegraven Netherlands 11 291 0.7× 208 0.7× 226 1.4× 124 1.0× 19 0.2× 29 554
David Drobne Slovenia 13 420 1.1× 288 0.9× 127 0.8× 218 1.8× 39 0.4× 50 599
Seid Hossein Mir‐Madjlessi United States 15 315 0.8× 335 1.1× 358 2.2× 35 0.3× 122 1.2× 22 717
Cristina B. Geltzeiler United States 10 81 0.2× 83 0.3× 275 1.7× 26 0.2× 174 1.8× 15 503
K Koss United Kingdom 6 72 0.2× 211 0.7× 77 0.5× 121 1.0× 59 0.6× 8 447

Countries citing papers authored by Steven Bots

Since Specialization
Citations

This map shows the geographic impact of Steven Bots's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Bots with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Bots more than expected).

Fields of papers citing papers by Steven Bots

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Bots. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Bots. The network helps show where Steven Bots may publish in the future.

Co-authorship network of co-authors of Steven Bots

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Bots. A scholar is included among the top collaborators of Steven Bots based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Bots. Steven Bots is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Voogd, F de, Steven Bots, K Gecse, et al.. (2022). Intestinal Ultrasound Early on in Treatment Follow-up Predicts Endoscopic Response to Anti-TNFα Treatment in Crohn’s Disease. Journal of Crohn s and Colitis. 16(10). 1598–1608. 36 indexed citations
3.
Voogd, F de, Aart Mookhoek, Steven Bots, et al.. (2022). Intestinal Ultrasound Is Accurate to Determine Endoscopic Response and Remission in Patients With Moderate to Severe Ulcerative Colitis: A Longitudinal Prospective Cohort Study. Gastroenterology. 163(6). 1569–1581. 49 indexed citations
4.
Bots, Steven, F de Voogd, Menno D. de Jong, et al.. (2021). Point-of-care Intestinal Ultrasound in IBD Patients: Disease Management and Diagnostic Yield in a Real-world Cohort and Proposal of a Point-of-care Algorithm. Journal of Crohn s and Colitis. 16(4). 606–615. 34 indexed citations
5.
Voogd, F de, et al.. (2021). Intestinal Ultrasound to Evaluate Treatment Response During Pregnancy in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 28(7). 1045–1052. 32 indexed citations
6.
Bots, Steven, Claire E. Parker, Johannan F. Brandse, et al.. (2021). Anti-Drug Antibody Formation Against Biologic Agents in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. BioDrugs. 35(6). 715–733. 46 indexed citations
8.
Bots, Steven, Kim Nylund, Mark Löwenberg, K Gecse, & Geert D’Haens. (2021). Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound Index. Journal of Crohn s and Colitis. 15(8). 1264–1271. 66 indexed citations
9.
Bots, Steven, Kim Nylund, & K Gecse. (2021). ‘Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a Novel UC-Ultrasound Index’. Journal of Crohn s and Colitis. 16(2). 337–337. 3 indexed citations
10.
Bots, Steven, Cyriel Y. Ponsioen, K Gecse, et al.. (2019). Relapse rates and predictors for relapse in a real-life cohort of IBD patients after discontinuation of anti-TNF therapy. Scandinavian Journal of Gastroenterology. 54(3). 281–288. 24 indexed citations
11.
Woude, C. Janneke van der, Daan Nieboer, Ewout W. Steyerberg, et al.. (2019). P138 Prediction model to safely cease anti-TNF therapy in Crohn’s disease: individual patient data meta-analysis (IPD-MA). Journal of Crohn s and Colitis. 13(Supplement_1). S158–S159.
12.
Bots, Steven, K Gecse, Murray L. Barclay, & Geert D’Haens. (2018). Combination Immunosuppression in IBD. Inflammatory Bowel Diseases. 24(3). 539–545. 41 indexed citations
13.
Bots, Steven, Nanne K.H. de Boer, K Gecse, et al.. (2018). P376 Clinical effectiveness of vedolizumab in a tertiary care cohort of IBD patients. Journal of Crohn s and Colitis. 12(supplement_1). S294–S295. 3 indexed citations
14.
Bots, Steven, Kim Nylund, Mark Löwenberg, et al.. (2018). Ultrasound for Assessing Disease Activity in IBD Patients: A Systematic Review of Activity Scores. Journal of Crohn s and Colitis. 12(8). 920–929. 77 indexed citations
15.
Bots, Steven, et al.. (2017). Patterns of anti-TNF use and associated treatment outcomes in inflammatory bowel disease patients: results from an analysis of Dutch health insurance claims data.. PubMed. 75(10). 432–442. 8 indexed citations
16.
Bots, Steven, Daniël R. Hoekman, Marc A. Benninga, et al.. (2017). Patterns of Anti-TNF Use and Associated Treatment Outcomes in Inflammatory Bowel Disease Patients: Results from an Analysis of Dutch Health Insurance Claims Data. Gastroenterology. 152(5). S58–S58. 6 indexed citations
17.
Bots, Steven, et al.. (2016). Mo1911 Relapse Risk and Predictors for Relapse in a Real-Life Cohort of IBD Patients After Discontinuation of Anti-TNF Therapy. Gastroenterology. 150(4). S814–S814. 1 indexed citations
18.
Sideras, Kostandinos, Steven Bots, Katharina Biermann, et al.. (2015). Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area. British Journal of Cancer. 112(12). 1911–1920. 38 indexed citations
19.
Strik, Anne S., Steven Bots, Geert D’Haens, & Mark Löwenberg. (2015). Optimization of anti-TNF therapy in patients with Inflammatory Bowel Disease. Expert Review of Clinical Pharmacology. 9(3). 429–439. 39 indexed citations
20.
Sideras, Kostandinos, Wenjia Wang, Wenjun Cao, et al.. (2014). SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma. Oncogene. 34(39). 5055–5068. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026